This month's issue of the Journal includes an article focusing on diagnosing heart failure in children. 1 The image that most readily comes to mind of a patient in heart failure is that of a middle-aged or older adult. A patient population was studied of subjects as young as 5 years old who had several types of congenital heart disease (CHD). While the need to evaluate heart failure is not surprising in an elderly subject, it is startling to encounter heart failure in a patient who is only 5 years old. The other unusual aspect of this paper is that investigations related to congenital abnormalities usually involve populations comprised of children, but the subjects studied in this study were not only minors; the oldest patient was 85 years old. This is an unusual patient population, but not so unusual as to be clinically irrelevant. CHD is the most common congenital birth defect, with an estimated prevalence of 8 per 1,000 live births. 2 The most common congenital heart lesion is ventricular septal defect, followed by atrial septal defect, patent ductus arteriosus, coarctation of the aorta, Tetralogy of Fallot, and transposition of great arteries. 3 The etiology of CHD is multifactorial, with most cases attributed to genetic predisposition and environmental factors. A smaller percentage of cases arise from chromosomal abnormalities. 4 It is in the youngest patients for whom there is the greatest potential for significant improvement in quality of life. Clinicians wish to provide optimum medical care for each patient, regardless of age. By intervening positively at ages as young as 5, there is the prospect of effecting improvements in health to realize many decades of a high quality of life for an individual. But, inevitably, attendant on circumstances with the greatest potential rewards are the greatest potential risks.
All imaging procedures that use ionizing radiation unavoidably deliver radiation dose to patients, and there currently is a concerted effort to reduce diagnostic radiation dose across all patient groups. 5 Nuclear medicine has a long history of conscientiously limiting the amount of injected activity so as to deliver radiation doses on average that are so low that they are comparable to the amount of dose received by most people due to the unavoidable background radiation. The mean dose that non-occupationally exposed individuals receive is estimated to be 3 mSv per year, while occupationally exposed individuals are allowed by law to receive 50 mSv per year. 6 For many years, administered activity was limited to deliver less than 50 mSv to the target organ for diagnostic nuclear medicine procedures. More recently the goal has been to limit delivered whole body dose to 10 mSv per imaging session. Some imaging studies have reported modifications of SPECT procedures that have achieved mean dose of only 1 mSv per injection. 7 For context, the amount of radiation dose was estimated to be 12.5 mSv from SPECT/CT and even less, at only 2 mSv, from 13 N-ammonia PET/CT, in the current paper.
It is necessary to take into account that the same amount of radiation dose is associated with different levels of radiation risks for different types of patients and for different organ systems. Radiation risks specific to children occur at lower dose than in adults. 8 Furthermore, risk assessments by age and gender have demonstrated that the younger the patient, the greater the radiation risk, as is particularly evident in children requiring multiple CT examinations prior to undergoing surgical repair for congenital abnormalities. 9 Because of the young age of many of these subjects, there are compounded risks from radiation effective dose resulting from multiple diagnostic procedures that use ionizing radiation, 10 which if not closely monitored could become excessive. Triggering the development of leukemia is a particular concern in the youngest patients, as has been seen in pediatric populations requiring multiple CT evaluations because of life-threatening conditions, for whom cumulated dose can reach 100 mSv. 11 Conversely, there are the risks involved with doing nothing if CHD is not addressed. Untreated, even simple CHD causes many deleterious effects, including growth retardation, reduced exercise tolerance, and behavioral abnormalities, all of which require medical therapy and frequent hospitalizations, with poor overall prognosis. 12 Complex congenital heart lesions have both cardiac and non-cardiac complications. Cardiac complications include bacterial endocarditis, embolic events, arrhythmias, ventricular dysfunction, valvular lesions, hypertension, aneurysms, and eventually heart failure. 3 Non-cardiac comorbidities include renal, pulmonary, and hepatic dysfunction. For children with Tetralogy of Fallot, only 11% of un-operated patients are alive by 20 years old and only 3% by age 40. 3 Children with transposition of the great arteries rarely survive past childhood without surgical intervention. Developments and improvement in surgical techniques and the interventional catheter-based therapies have led to significant improvements in outcomes for patients with CHD. 13, 14 Thus, a balance must be struck between potential risks versus potential benefits, and in the case of pediatric cardiology this is an area of medicine in which that need is pronounced. Attempting to achieve this balance only by reducing administered activity in conjunction with using conventional imaging technology can be selfdefeating, as that invites the risk of misdiagnosing cardiac disease due to inadequate image quality if so little activity is administered that the reliability of imaging interpretation becomes suboptimal, as signal-to-noise degrades progressively with decreasing image counts.
Nuclear cardiologic techniques were an early contributor to the diagnosis and evaluation of CHD. Maltz et al refined a radionuclide angiocardiography technique to non-invasively estimate shunt fraction using first-pass time activity curves. 15 Equilibrium radionuclide
angiography was used to demonstrate that in patients who had the Mustard procedure for D-transpositions, right and left EF was normal but failed to increase with maximal exercise, a pattern that persisted over 4 years of subsequent follow-up. 16 201 Tl SPECT myocardial perfusion imaging evaluated patients who had D-transposition treated with the arterial switch operation, finding 43% of patients demonstrated fixed or reversible defects.
17 99m Tc-MIBI SPECT showed that 25% of patients exhibited myocardial perfusion defects several years after the arterial switch operation. 18 Abnormal coronary flow could contribute to the late development of reduced cardiac function post-op and to sudden cardiac death. 17, 18 Contemporaneous catheterization studies confirmed that some patients have coronary stenoses following the arterial switch procedure, with rare instances of late mortality and sudden death. 19 While advances in cardiac CT have enabled evaluating the anatomic course and potential obstructions of aberrant coronary arteries, 20 a role persists for myocardial perfusion imaging in CHD, particularly in clinical situations in which angina or myocardial ischemia are suspected. 21, 22 Improved outcomes of CHD patients have fostered long-term survival, such that conventional coronary risk factors may produce atherosclerotic cardiovascular disease. A review of patients with CHD who developed symptomatic coronary disease found that most patients had significant coronary risk factors, and that patients with coarctation of the aorta tended to present at an earlier age, attributable to sustained hypertension, which is common in this group. 23 Some categories of CHD are associated with abnormalities of the coronaries, 24 or inadequate coronary flow, 25 either as a primary syndrome, or as a sequelae of the curative surgery.
The current article explored the ways in which recent technological advances have enabled a rebalancing of risk-benefit ratios, suggesting which particular nuclear cardiology imaging approaches have now become advantageous for younger patients who require multiple repeated imaging evaluations. The case is made for tailoring procedures with the age of the subjects in mind: predictably, estimated radiation dose was higher in those children who were administered the same activity as an adult as opposed to those for whom weight-based activity administration was used.
In the current study, radiation dose was estimated rather than measured. That is understandable, as the logistics of directly measuring radiation dose are challenging. 26 While CT scanners can incorporate sensors to produce reasonable estimates of entrance dose to the skin, the organ receiving the highest dose from CT imaging, target organs that receive the maximum dose from administration of radiopharmaceuticals are inaccessibly internal (bone marrow, liver, kidneys, etc.) and delivered organ radiation dose depends on which particular radiopharmaceutical is used. 27 Organ doses are estimated for patients in general, not assessed individually on a patient-by-patient basis. Efforts are ongoing to combine PET with CT scans to produce a detailed map of radiation dose delivered to individual organs for individual patients for radiotherapy procedures such as 131 I therapy for thyroid cancer. 28 But these approaches are only now in the research phase, and the ability to attempt anything comparable for pediatric nuclear cardiology studies must await future developments.
While refining actual delivered radiation dose to each individual patient will require further future innovations, the technological advances of the past few years already have afforded considerable improvements in dose reduction and expansion of the options that are now currently available, and that is the focus of the investigation by Partington et al. 1 For hybrid imaging procedures, radiation dose for the CT component can be limited by employing newer software that enables estimating CT radiation dose prior to choosing a particular CT protocol for a younger patient, allowing clinicians to determine the likely differences that would result from different choices of CT settings. As for SPECT imaging procedures, in an imaging laboratory that has both types of equipment, it would be preferable to use CZT cameras as opposed to conventional NaI(Tl)-based Anger detectors for pediatric cases in order to enable injecting a lower amount of activity to achieve the same count rate. 29 Technical advances in SPECT systems have resulted in greatly enhanced machine sensitivity and spatial resolution. 30 Also, consider the 13 N-amonia PET/CT procedures that are discussed in the current paper. The radiopharmaceutical was already well suited to pediatric nuclear cardiology due to its delivering low radiation dose by virtue of its rapid washout and short half-life. What inhibited a more wide-spread usage of this agent was that until recently it was necessary to have in-house a major cyclotron, or be fortunate enough to be located within only a few miles of a facility. But now, deploying 13 N-amonia PET more widely is becoming more feasible as compact superconducting cyclotrons that generate individual amounts of injectate on an ''as-needs'' basis have become available for purchase or lease. Also, technical improvements in the PET scanners used to produce the perfusion images are much more sensitive than previously. Replacing 2D PET with 3D PET, implementing time-of-flight electronics and replacing conventional photomultiplier tubes all have produced higher-count, higher-sensitivity, and higher signal-tonoise ratio images than have previously been possible. These PET imaging innovations have advanced rapidly, with improvements in detector designs and electronics going hand-in-hand with developments in computer science and image modeling that have vastly improved and accelerated reconstruction algorithms. Furthermore, efforts are underway to replace the CT component of PET/CT, with its own unavoidable radiation dose delivery, with MRI; studies already are underway to define optimal amounts of tracer activity to administer in conjunction with PET/MRI technology for pediatric evaluations. 31 In summary, the article by Partington et al makes several important points. The prevalence of abnormal myocardial perfusion and ischemia findings among patients with CHD is quite high, and considering the seriousness of these and related deleterious conditions, it is important to monitor patients with CHD and intervene medically in an effective manner. The delivery of radiation dose in the process of evaluating such patients is unavoidable, but it is possible to balance the long-term risks of radiation exposure in children with the benefits of accurate diagnostic information by means of the technical advances that have enabled highly accurate evaluations while limiting radiation dose. This article by Partington et al provides valuable guidance for achieving this balance.
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